What is more, since uPAR is expressed in multiple types of cancer, the generated compound offers potential to be utilized for the targeting of not only brain tumors, but also adenocarcinomas of the pancreas, colorectum, stomach, cervix, as well as carcinomas of esophagus, head and neck, and breast among many others.[16, 52] We acknowledge that the tracer we developed requires additional assessment in other cancer types to verify this statement. The gene discussed is PLAUR; the disease is carcinoma of esophagus.